Researchers said they found a link between malaria and a gene that helps control cholesterol uptake in the liver. The study -- a collaboration from Alnylam Pharmaceuticals, Germany's Cenix BioScience and Portugal's Instituto de Medicina Molecular -- could lead to malaria treatments, including RNAi-based drugs that could switch off the genes that cause the disease.

Related Summaries